Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact? - 07/08/11
Doi : 10.1016/j.jaci.2010.06.041
Collin R. Brooks, BSc (Hons) a 
, Robert Weinkove, MBBS b, Ian F. Hermans, PhD b, Christine J. van Dalen, PhD, MBChB a, Jeroen Douwes, PhD a
, Robert Weinkove, MBBS b, Ian F. Hermans, PhD b, Christine J. van Dalen, PhD, MBChB a, Jeroen Douwes, PhD a a Centre for Public Health Research, Massey University, Wellington Campus, Wellington, New Zealand
b Malaghan Institute of Medical Research, Wellington, New Zealand
| Disclosure of potential conflict of interest: R. Weinkove has received research support from the Genesis Oncology Trust, the New Zealand Lottery Grants Board, and Infinity Foundation. I. F. Hermans has received research support from the Health Research Council of New Zealand and the Cancer Society of New Zealand. J. Douwes has received research support from the New Zealand Health Research Council. The rest of the authors have declared that they have no conflict of interest. |
|
| Supported by the Health Research Council of New Zealand and the Asthma and Respiratory Foundation of New Zealand. R. W. is supported by Genesis Oncology Trust and a New Zealand Lotteries Grant. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 126 - N° 4
P. 882-885 - octobre 2010 Regresar al número
Artículo precedente
- Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia
- Hak-Ryul Kim, Chang-Duk Jun, Young-Jin Lee, Sei-Hoon Yang, Eun-Taik Jeong, Seok-Don Park, Do-Sim Park
- Correction
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?